| Bioactivity | Bivalirudin, a peptide anticoagulant, is a direct thrombin inhibitor for anticoagulation in the setting of invasive cardiology, particularly percutaneous coronary intervention[1][2]. | ||||||
| Name | Bivalirudin | ||||||
| CAS | 128270-60-0 | ||||||
| Sequence | {d-Phe}-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-ILE-Pro-Glu-Glu-Tyr-Leu | ||||||
| Shortening | {d-Phe}-PRPGGGGNGDFEEIPEEYL | ||||||
| Formula | C98H138N24O33 | ||||||
| Molar Mass | 2180.29 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Bivalirudin
CAS: 128270-60-0 F: C98H138N24O33 W: 2180.29
Bivalirudin, a peptide anticoagulant, is a direct thrombin inhibitor for anticoagulation in the setting of invasive card
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.